MLB Drug Policy Memo (1997, Selig)

From WikiLeague, the free baseball governance encyclopedia.

Needs review. This document is in the archive but has not yet been confirmed against a second independent source. Per editorial standards, only verified documents should be cited as authoritative. Use this page for reference, but cross-check against the linked source(s) before citing.

The successor to the 1991 Vincent Drug Memo and the predecessor to the 2002 Joint Drug Agreement. Commissioner Bud Selig's 1997 drug-policy memo, issued midway between the Vincent-era (1991) drug program and the eventual collectively-bargained Joint Drug Agreement embedded in the 2002-2006 CBA (in this archive). Six pages, image-only scan. The Selig 1997 memo represents the late-Selig pre-Mitchell-Report era of unilateral commissioner drug policy — the period in which the steroid era's most prominent offensive numbers (McGwire/Sosa 1998 HR chase, Bonds 2001 73-HR season) occurred under a drug-testing regime later widely characterized as inadequate. Drug-policy chain: 1991 Vincent Memo → 1997 Selig Memo (this document) → 2002 JDA (embedded in 2002-2006 CBA) → 2005 mid-cycle JDA renegotiation (driven by the steroid hearings) → 2007 Mitchell Report → ongoing JDPTP updates in each subsequent CBA. Page-level content review deferred — image-only PDF; the substantive provisions (testing protocols, penalty structure, list of prohibited substances) require OCR or manual review.

Background

Bridges the Vincent-era voluntary drug policy and the post-2002 JDA framework. The 1997 Selig memo was the operative drug policy during the McGwire-Sosa 1998 HR chase. OCR and content review remain outstanding — the substantive provisions of the 1997 memo are not yet captured in the metadata.

Key provisions

  • [Detailed content review deferred — image-only PDF, no text layer.]

Further context

1997 MLB Drug Policy Memo (Selig)

The bridge document between the 1991 Vincent drug memo and the 2002 Joint Drug Agreement. Operative during the McGwire/Sosa 1998 HR chase. 6 pages, image-only scan.

Source: SABR Business of Baseball Files.

Detailed content review deferred (no OCR text layer).

References

  1. Primary source: sabr.app.box.com — MLB Office of the Commissioner; archived by SABR Business of Baseball Files, retrieved 2026-05-18.
  2. Confirmation source: sabr.app.box.com — SABR Business of Baseball Files.
  3. File fingerprint: SHA256 e3db5e044cf957266264ce2961293734dc15c2562fee89af3aed3a83cde6aa09.

Evidence trail

Per archive editorial standards §1.3 and §1.4, verified documents require two independent confirmation sources and an archive.org snapshot. This panel is the integrity record the archive holds for this document.

File integrity

SHA256
e3db5e044cf957266264ce2961293734dc15c2562fee89af3aed3a83cde6aa09
Filename
1997_memo_selig-drug-policy-program.pdf
Format
PDF · 6 pp · 506 KB
Retrieved
2026-05-18 by claude/cowork-9167cb28 (uploaded by alex)
Primary URL
https://sabr.app.box.com/s/9fd49f1p19rrgaist26tj7km6a7m0l31

Confirmation sources (1)

Publisher Retrieved URL Notes
SABR Business of Baseball Files 2026-05-18 https://sabr.app.box.com/s/9fd49f1p19rrgaist26tj7km6a7m0l31

Most recent status change

needs_review on 2026-05-18 by claude/cowork-9167cb28.

**Phase 1 wantlist hit cleared.** 1997 Selig Drug Memo acquired via SABR Business of Baseball Files. The second document in the Vincent → Selig → JDA pre-modern-drug-policy chain.

Source provenance